Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Flavorings, colors and sweeteners emerge as UPF markers linked to depression risk

1

Sep 2026

Flavorings, colors and sweeteners emerge as UPF markers linked to depression risk

A prospective UK Biobank study of 171,818 adults found that greater estimated exposure to foods containing flavorings, coloring agents, and sweeteners was dose-dependently associated with a higher risk of incident depression over 10.7 years. The findings suggest that specific markers, rather than ultra-processed foods uniformly, may help explain associations between UPF consumption and depression risk.

Researchers found one childhood behavior linked to folic acid use before pregnancy

1

Sep 2026

Researchers found one childhood behavior linked to folic acid use before pregnancy

Researchers analyzed 646 children aged 2–8 years and their 563 mothers to examine whether maternal folic acid supplementation before conception was associated with childhood behavioral difficulties. Preconception supplementation was associated with a 34% lower risk of peer relationship problems, while no significant associations were found for total behavioral difficulties, emotional, conduct, hyperactivity/inattention, or prosocial problems.

Seafood at breakfast stood out in a study of nearly 6,000 adults

1

Sep 2026

Seafood at breakfast stood out in a study of nearly 6,000 adults

Researchers analyzed dietary and sleep data from 5,975 Japanese adults to examine whether seafood, EPA, and DHA intake at different meal occasions was associated with chronotype and social jetlag. Higher intake at breakfast showed the strongest association with earlier sleep timing and less social jetlag, although the cross-sectional design cannot establish whether dietary timing influences sleep patterns or vice versa.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.